Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Sep 13;220(8):1325-1334.
doi: 10.1093/infdis/jiz294.

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

Affiliations
Clinical Trial

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

Christina Ekenberg et al. J Infect Dis. .

Abstract

The impact of variation in host genetics on replication of human immunodeficiency virus type 1 (HIV-1) in demographically diverse populations remains uncertain. In the current study, we performed a genome-wide screen for associations of single-nucleotide polymorphisms (SNPs) to viral load (VL) in antiretroviral therapy-naive participants (n = 2440) with varying demographics from the Strategic Timing of AntiRetroviral Treatment (START) trial. Associations were assessed using genotypic data generated by a customized SNP array, imputed HLA alleles, and multiple linear regression. Genome-wide significant associations between SNPs and VL were observed in the major histocompatibility complex class I region (MHC I), with effect sizes ranging between 0.14 and 0.39 log10 VL (copies/mL). Supporting the SNP findings, we identified several HLA alleles significantly associated with VL, extending prior observations that the (MHC I) is a major host determinant of HIV-1 control with shared genetic variants across diverse populations and underscoring the limitations of genome-wide association studies as being merely a screening tool.

Keywords: GWAS; HIV-1; HLA; genome-wide association study; host genetics; viral load.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Single-nucleotide polymorphisms (SNPs) associated with viral load. The Manhattan plot shows the association between SNPs and log10 viral load in the cohort. Each SNP is represented by a point and plotted by chromosomal location (x-axis), and –log10(P-value) per SNP is shown on the y-axis. Genome-wide significance is indicated by the horizontal red line (P-value < 5 × 10–8).
Figure 2.
Figure 2.
Summary of genome-wide significant major histocompatibility complex class I (MHC I) single-nucleotide polymorphisms (SNPs) associated with viral load. A, The location of the 5 significant SNPs in the MHC I region of chromosome 6 and a heatmap of linkage disequilibrium highlighting local structures of SNPs in linkage disequilibrium with one another. The positions of the top 5 SNPs are shown as blue points. B, Violin plots of viral load distributions for each of the 5 SNPs and their different genotypes. Abbreviations: alt/alt, homozygotes for the alternate allele; kb, kilobase; ref/alt, heterozygotes; ref/ref, homozygotes for the reference allele; VL, viral load.
Figure 3.
Figure 3.
Effect sizes (including 95% confidence intervals [CIs]) of significant single-nucleotide polymorphisms (SNPs) associated with viral load. The effect size (beta) is the difference in log10 viral load per additional alternate allele. The covariates included in the regression analysis were the leading 4 eigenvectors and sex.

Similar articles

Cited by

References

    1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167–70. - PubMed
    1. Bartha I, Carlson JM, Brumme CJ, et al. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. Elife 2013; 2:e01123. - PMC - PubMed
    1. Bartha I, McLaren PJ, Brumme C, Harrigan R, Telenti A, Fellay J. Estimating the respective contributions of human and viral genetic variation to HIV control. PLoS Comput Biol 2017; 13:e1005339. - PMC - PubMed
    1. McLaren PJ, Coulonges C, Bartha I, et al. Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A 2015; 112:14658–63. - PMC - PubMed
    1. Fellay J, Ge D, Shianna KV, et al. ; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791. - PMC - PubMed

Publication types

MeSH terms

Substances